HeartSciences Inc. (HSCS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $10.56M
Last updated: Nov 17, 2026 at 4:10 PM ET
HeartSciences Inc. (HSCS) Statistics
HeartSciences (HSCS) has a market cap of $10.56M and an enterprise value of $14.39M. Its share count is up 181.46% from a year earlier.
Total Valuation
Enterprise value is 36.27% above the market cap, as debt exceeds cash.
| Market Cap | $10.56M |
|---|---|
| Enterprise Value | $14.39M |
| Latest price (Nov 17, 2026) | $2.06 |
Key Dates
The next earnings report is expected on Dec 21, 2026, covering the quarter ending Oct 31, 2026.
| Next Earnings Date | Dec 21, 2026 (expected) |
|---|---|
| Last Earnings Date | Sep 14, 2026 |
| Fiscal Year End | April |
Price Statistics
The stock is down 32.90% over 52 weeks and trades 40.29% below its 50-day average.
| Beta (1Y) | 0.72 |
|---|---|
| 52-Week Change | -32.90% |
| 1-Month Change | -32.90% |
| 3-Month Change | -19.06% |
| 6-Month Change | +9.57% |
| Total Return (1Y) | -32.90% |
| Total Return (3Y CAGR) | -50.08% |
| Return vs SPY (1Y) | -43.57% |
| Max Drawdown (1Y) | -60.38% |
| Max Drawdown (3Y) | -93.74% |
| Sharpe Ratio (1Y) | -0.37 |
| Correlation with SPY (1Y) | 0.09 |
| 50-Day Average | $3.45 |
| 200-Day Average | $2.67 |
| 52-Week Range | $1.63 to $5.25 |
| RSI (14 Days) | 31.5 |
| Average Volume (20 Days) | 90.60K |
Financial Position
Current assets cover 0.14x current liabilities.
| Current Ratio | 0.14x |
|---|---|
| Quick Ratio | 0.07x |
| Interest Coverage | -11.75x |
Returns and Efficiency
Return on invested capital is -408.80% over the last 12 months.
| Return on Assets (ROA) | -274.52% |
|---|---|
| Return on Invested Capital (ROIC) | -408.80% |
| Inventory Turnover | 0.00x |
Scores
HSCS has an Altman Z-Score of -42.24, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -42.24 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Balance Sheet
| Cash and Equivalents | $29.91K |
|---|---|
| Total Debt | $3.86M |
| Net Debt | $3.83M |
| Net Debt Per Share | $1.04 |
| Working Capital | -$4.82M |
| Shareholder Equity | -$2.03M |
| Tangible Book Value | -$4.69M |
| Total Assets | $3.74M |
| Total Liabilities | $5.77M |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $28.80M of capital spending, operating cash flow left -$35.59M of free cash flow.
| Operating Cash Flow | -$6.79M |
|---|---|
| Capital Expenditures | $28.80M |
| Free Cash Flow | -$35.59M |
| FCF Per Share | -$7.35 |
| Depreciation and Amortization | $65.18M |
Trailing 12 months through Jul 31, 2026.
Growth
Revenue fell 5.70% a year over 3 years.
| Revenue Growth (3Y CAGR) | -5.70% |
|---|---|
| Revenue Growth (5Y CAGR) | -29.95% |
Stock Splits
The last split was a 1-for-100 reverse split on May 17, 2024.
| Last Split Date | May 17, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:100 |
Analyst Forecast
Consensus estimates put revenue growth at 2600.62% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2600.62% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About HSCS
What is HSCS's market cap?
HeartSciences has a market cap of $10.56M. Its enterprise value, which adds debt and subtracts cash, is $14.39M.
How many shares of HSCS are outstanding?
HeartSciences has 3.67M shares outstanding. The count is up 181.46% from a year earlier.
Does HSCS pay a dividend?
No. HeartSciences does not pay a dividend.
How much debt does HSCS have?
HeartSciences has $3.86M of total debt and $29.91K of cash and equivalents, a net debt position of $3.83M.
HSCS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors